{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:10:53Z","timestamp":1761513053448},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/aog.0b013e318233beae","type":"journal-article","created":{"date-parts":[[2011,11,22]],"date-time":"2011-11-22T10:52:18Z","timestamp":1321959138000},"page":"1331-1336","source":"Crossref","is-referenced-by-count":15,"title":["Continuation Rates and Complications of Intrauterine Contraception in Women Diagnosed With Bipolar Disorder"],"prefix":"10.1097","volume":"118","author":[{"given":"Abbey B.","family":"Berenson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humera","family":"Asem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alai","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregg S.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-18-20210328","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":". Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication.","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"R2-18-20210328","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.clinpsy.3.022806.091444","article-title":"Prevalence, comorbidity, and service utilization for mood disorders in the United States at the beginning of the twenty-first century.","volume":"3","author":"Kessler","year":"2007","journal-title":"Annu Rev Clin Psychol"},{"key":"R4-18-20210328","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.drugalcdep.2007.07.013","article-title":"HIV risk behavior among patients with co-occurring bipolar and substance use disorders: associations with mania and drug abuse.","volume":"92","author":"Meade","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"R5-18-20210328","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00737-009-0060-y","article-title":"Use of contraceptive methods among women treated for bipolar disorder.","volume":"12","author":"Magalhaes","year":"2009","journal-title":"Arch Womens Ment Health"},{"issue":"suppl 1","key":"R6-18-20210328","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1399-5618.2005.00190.x","article-title":"Women are not the same as men: specific clinical issues for female patients with bipolar disorder.","volume":"7","author":"Curtis","year":"2005","journal-title":"Bipolar Disord"},{"key":"R7-18-20210328","doi-asserted-by":"crossref","first-page":"231","DOI":"10.5694\/j.1326-5377.1997.tb140100.x","article-title":"Sexually transmitted diseases and unwanted pregnancies in chronically ill psychiatric patients.","volume":"166","author":"Coverdale","year":"1997","journal-title":"Med J Aust"},{"key":"R8-18-20210328","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1192\/bjp.171.1.69","article-title":"Family planning needs and STD risk behaviours of female psychiatric out-patients.","volume":"171","author":"Coverdale","year":"1997","journal-title":"Br J Psychiatry"},{"key":"R9-18-20210328","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2165\/00023210-200216040-00005","article-title":"Interactions between antiepileptic drugs and hormonal contraception.","volume":"16","author":"Crawford","year":"2002","journal-title":"CNS Drugs"},{"key":"R10-18-20210328","first-page":"1","article-title":"US medical eligibility criteria for contraceptive use, 2010.","volume":"59","year":"2010","journal-title":"MMWR Recomm Rep"},{"key":"R11-18-20210328","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0074-7742(08)00006-8","article-title":"Contraception in women with epilepsy: pharmacokinetic interactions, contraceptive options, and management.","volume":"83","author":"Dutton","year":"2008","journal-title":"Int Rev Neurobiol"},{"key":"R12-18-20210328","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy.","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"key":"R13-18-20210328","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.nmd.0000120888.45094.38","article-title":"HIV risk behavior among psychiatric outpatients: association with psychiatric disorder, substance use disorder, and gender.","volume":"192","author":"Carey","year":"2004","journal-title":"J Nerv Ment Dis"},{"key":"R14-18-20210328","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/pds.2630040407","article-title":"Use of insurance claims in epidemiologic research: identification of peptic ulcers, GI bleeding, pancreatitis, hepatitis, and renal disease.","volume":"4","author":"Lanza","year":"1995","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R15-18-20210328","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/pds.725","article-title":"Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States.","volume":"11","author":"Enger","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R16-18-20210328","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1002\/pds.1356","article-title":"The risk of coronary heart disease in type 2 diabetic patients exposed to thiazolidinediones compared to metformin and sulfonylurea therapy.","volume":"16","author":"Johannes","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"suppl 7","key":"R17-18-20210328","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S1092852900002327","article-title":"Bipolar disorders: special diagnostic and treatment considerations in women.","volume":"9","author":"McElroy","year":"2004","journal-title":"CNS Spectr"},{"key":"R18-18-20210328","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1192\/apt.bp.107.004903","article-title":"The course of bipolar disorder.","volume":"16","author":"Saunders","year":"2010","journal-title":"Advances in Psychiatric Treatment"},{"key":"R20-18-20210328","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/AOG.0b013e31821188ad","article-title":". Continuation and satisfaction of reversible contraception.","volume":"117","author":"Peipert","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R21-18-20210328","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0010-7824(97)00140-6","article-title":"Depot medroxyprogesterone acetate. Patterns of use and reasons for discontinuation.","volume":"56","author":"Paul","year":"1997","journal-title":"Contraception"},{"key":"R22-18-20210328","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0010-7824(99)00104-3","article-title":"Factors affecting continuation rates of DMPA.","volume":"60","author":"Hubacher","year":"1999","journal-title":"Contraception"},{"key":"R23-18-20210328","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2008.04.048","article-title":"Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills.","volume":"199","author":"Berenson","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R24-18-20210328","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.contraception.2008.05.007","article-title":"Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth.","volume":"78","author":"Vaughan","year":"2008","journal-title":"Contraception"},{"key":"R26-18-20210328","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2307\/2136058","article-title":"Continuation rates among injectable contraceptive users.","volume":"28","author":"Westfall","year":"1996","journal-title":"Fam Plann Perspect"},{"key":"R27-18-20210328","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0029-7844(96)00194-9","article-title":"3rd, Bateman L, Ditmore JR. Experiences of injectable contraceptive users in an urban setting.","volume":"88","author":"Sangi-Haghpeykar","year":"1996","journal-title":"Obstet Gynecol"},{"key":"R28-18-20210328","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/AOG.0b013e31820563d3","article-title":". One-year contraceptive continuation and pregnancy in adolescent girls and women initiating hormonal contraceptives.","volume":"117","author":"Raine","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R30-18-20210328","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.contraception.2008.01.002","article-title":"Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database.","volume":"77","author":"Murphy","year":"2008","journal-title":"Contraception"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006250-201112000-00018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T05:40:08Z","timestamp":1618033208000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201112000-00018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e318233beae","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}